Biomarker ID | 1054 |
PMID | 23356551 |
Year | 2013 |
Biomarker | Prostate Specific Antigen (PSA) |
Biomarker Basis | Concentration Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | OR :1.04 (95% CI:1.03-1.05) |
Effect on Pathways | NA |
Experiment | PC (stage II, III, IV) vs. other (PC stage I, PIN, BPH, prostatitis) |
Type of Biomarker | Diagnostic |
Cohort | 616 US Veterans with Prostate Cancer, along with 732 patients categorised as non cancerous (342 Prostatis, 282 BPH, 138 PIN) were chosen for the study. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p < 0.001 |
Method Used | NA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |